Sites
When Do I Need an EAC?
View this infographic to learn when do you need an endpoint adjudication committee (EAC) and what types of studies an EAC reviews.
Cosmetic Research and IRB Review
Download the info sheet to learn about IRB review of cosmetics research, including applicable regulations and the IRB’s role.
5 Considerations for Evaluating an eIRB System
Provide guidance for research requests to the IRB, identify the appropriate regulations, and simplify the process from submission to review.
Reuniting and Reconnecting at the 2022 Onsemble Conference
The 2022 Onsemble Conference provided an opportunity for attendees to reconnect in person and collaborate to move research forward.
mRNA Clinical Trials: Key Regulatory Considerations
Responses to the most frequently asked questions regarding mRNA technology and clinical trial regulatory requirements.
Clinical Endpoint Adjudication Committees: Not Just for “Endpoints”
This blog outlines critical events where EACs are used to look at more than just “endpoints” in clinical research.
Let’s Get Ethical
Advarra's IRB Chairs Luke Gelinas and Amanda Higley discuss hot topics in clinical research, including cannabis studies and data ownership.
A Journey in Support of Diversity
Advarra's Sergio Armani introduces ACRP's Ride for Diversity program and why it's important to him personally and to the research community.
Top-Tier University Stays Compliant with Advarra’s HRPP Assessment
A top -tier university worked with Advarra’s Institutional Research Center of Excellence to assess HRPP compliance with federal regulations
Addressing Research Technology Challenges to Gain Sponsor Buy-in
Encouraging site-owned technology platforms enables site staff to produce their best work, increasing the likelihood of a study’s success.
Gene Therapy Ready Site Network
This info sheet describes Advarra’s Gene Therapy Ready site network and the benefits of joining the network.
The Rise of the Clinical Research Network: Using Technology to Connect Sites and Sponsors
An integrated approach to the clinical research industry’s technology landscape can improve access and diversity, save time, and better serve patients